RGT-61159
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RGT-61159, covering 2025-11-14 to 2025-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC) [Phase 1]